Distinct antibody responses as biomarkers to monitor cancer immunotherapies

12 August 2022
In a new study, researchers described how pre-existing and treatment-induced antibodies against specific antigen targets could reflect the response elicited by anti-tumour drugs and that this response could be predictive of cancer immunogenicity and therefore, sensitivity to immune therapy… Read More…